Department of Oncological and Surgical Sciences, Urology Clinic, University of Padua, Padua, Italy.
Eur Urol. 2010 Jun;57(6):1045-51. doi: 10.1016/j.eururo.2010.01.007. Epub 2010 Jan 16.
Orthotopic bladder reconstruction is the preferred method of urinary diversion following radical cystectomy (RC). Several papers reported functional data of different orthotopic neobladders, although to date, no one has used validated questionnaires.
To evaluate the midterm functional results in a contemporary series of patients undergoing RC and vescica ileale Padovana (VIP) orthotopic neobladder by applying a set of validated questionnaires.
DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional study at a single academic centre.
We included RC and VIP orthotopic techniques for bladder transitional cell carcinoma.
The American Urological Association Symptom Index (AUA-SI), the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), and the five-item version of the International Index of Erectile Function (IIEF-5) were used to evaluate functional outcomes.
All 113 patients who were alive and disease free at 44-mo follow-up were evaluated. Sixteen patients (13%) were on clean intermittent catheterisation (CIC). The median AUA-SI score of the 97 voiding patients was 9 (interquartile range [IQR]: 4.5-16). Specifically, 48.5%, 40.2%, and 11.3% of the patients had mild, moderate, or severe lower urinary tract symptoms (LUTS), respectively. American Society of Anaesthesiologists class (odds ratio [OR]: 9.0; p=0.03) and body mass index (OR: 1.5; p=0.023) were independent predictors of the need for CIC, while only patient age at the time of surgery (OR: 0.920; p=0.01) was predictive of LUTS severity. The median ICIQ-UI SF score was 6 (IQR: 3-10). Twenty patients (17.7%) were fully continent, while 31.9%, 35.4%, and 15% had slight, moderate, and severe incontinence, respectively. About 90% of the patients during the day and 80% during the night used no pad or only a safety pad. Most of the patients leaked when asleep. No variable was predictive of return to continence. Finally, roughly 20% of the male patients were potent, having an IIEF-5 score ≥17.
We reported midterm functional outcomes following RC and VIP neobladder using validated questionnaires. On the whole, the results are encouraging. However, in the absence of patient self-completed questionnaires, functional outcomes may be significantly overestimated.
根治性膀胱切除术(RC)后,首选的尿流改道术式是原位膀胱重建。已有多篇文献报道了不同原位新膀胱的功能数据,但迄今为止,尚无研究使用经过验证的问卷。
通过应用一组经过验证的问卷,评估 RC 和帕多瓦氏回肠代膀胱(VIP)原位新膀胱的中期功能结果。
设计、地点和参与者:我们在一个单中心进行了一项横断面研究。
我们纳入了 RC 和 VIP 原位技术用于治疗膀胱移行细胞癌。
采用美国泌尿协会症状指数(AUA-SI)、国际尿失禁咨询问卷-尿失禁简短表(ICIQ-UI SF)和国际勃起功能指数问卷-5 项版(IIEF-5)评估功能结局。
所有在 44 个月随访时存活且无疾病的 113 例患者均接受了评估。16 例(13%)患者需要间歇性清洁导尿(CIC)。97 例有排尿功能的患者的中位 AUA-SI 评分为 9 分(四分位距[IQR]:4.5-16)。具体而言,分别有 48.5%、40.2%和 11.3%的患者存在轻度、中度和重度下尿路症状(LUTS)。美国麻醉医师协会(ASA)分级(比值比[OR]:9.0;p=0.03)和体重指数(OR:1.5;p=0.023)是需要 CIC 的独立预测因素,而仅手术时患者年龄(OR:0.920;p=0.01)是 LUTS 严重程度的预测因素。中位 ICIQ-UI SF 评分为 6 分(IQR:3-10)。20 例(17.7%)患者完全控尿,而 31.9%、35.4%和 15%的患者有轻微、中度和重度尿失禁。大约 90%的患者白天和 80%的患者夜间不使用尿垫或仅使用安全垫。大多数患者在睡眠时漏尿。没有变量可以预测恢复控尿。最后,大约 20%的男性患者有勃起功能,即 IIEF-5 评分≥17。
我们使用经过验证的问卷报告了 RC 和 VIP 新膀胱的中期功能结果。总体而言,结果令人鼓舞。但是,由于缺乏患者自填问卷,功能结果可能会被显著高估。